Hematocrit control and thrombotic risk in patients with polycythemia vera treated with ruxolitinib in clinical practice
临床实践中，接受鲁索替尼治疗的真性红细胞增多症患者的血细胞比容控制和血栓形成风险
期刊:Annals of Hematology
影响因子:2.4
doi:10.1007/s00277-024-05735-7
Chojecki, Aleksander; Boselli, Danielle; Dortilus, Allison; Hamadeh, Issam; Begley, Stephanie; Chen, Tommy; Bose, Rupali; Podoltsev, Nikolai; Zeidan, Amer M; Balmaceda, Nicole Baranda; Yacoub, Abdulraheem; Ai, Jing; Knight, Thomas Gregory; Ragon, Brittany Knick; Shah, Nilay Arvind; Sanikommu, Srinivasa Reddy; Symanowski, James; Mesa, Ruben; Grunwald, Michael Richard
